Zummo Jacqueline
SEC CIK 1798929 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TARA | Protara Therapeutics, Inc. | Chief R, D Off | 94.8K | — | $221.1K | 18 | 2022-01-03 | 2026-04-08 |
Most active insiders at TARA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Shefferman Jesse | CEO, Pres, Dir | — | $882.2K |
| 2 | Zummo Jacqueline | Chief R, D Off | — | $125.0K |
| 3 | Nicacio Leonardo Viana | Chief Medical Off | — | — |
| 4 | Fry Hannah | VP, Ctrl | — | — |
| 5 | CONKLING WILLIAM | Chief Commercial Off | — | — |
| 6 | Fabbio Patrick | CFO | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-09 17:25 | 2026-04-08 | TARA | Protara Therapeutics, Inc. | Zummo Jacqueline | Chief R, D Off | S - Sale | $5.40 | -1,134 | 94.8K | -1% | -$6,124 | |
| 2026-04-02 16:05 | 2026-04-01 | TARA | Protara Therapeutics, Inc. | Zummo Jacqueline | Chief R, D Off | S - Sale | $5.26 | -22.6K | 96.0K | -19% | -$118.9K | |
| 2026-01-27 | 2026-01-26 | TARA | Protara Therapeutics, Inc. | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $6.67 | -3,724 | 118.6K | -3% | -$24.8K | |
| 2026-01-22 | 2026-01-20 | TARA | Protara Therapeutics, Inc. | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $5.60 | -6,578 | 122.3K | -5% | -$36.8K | |
| D | 2026-01-21 | 2026-01-16 | TARA | Protara Therapeutics, Inc. | Zummo Jacqueline | Chf Scientific Ops Off | A - Grant | $0.00 | +30.0K | 128.9K | +30% | $0 |
| 2025-03-28 | 2025-03-26 | TARA | Protara Therapeutics, Inc. | Zummo Jacqueline | Chf Scientific Ops Off | S - Sale | $4.53 | -21.2K | 98.9K | -18% | -$96.1K | |
| D | 2025-01-28 | 2025-01-24 | TARA | Protara Therapeutics, Inc. | Zummo Jacqueline | Chf Scientific Ops Off | A - Grant | $0.00 | +24.5K | 126.6K | +24% | $0 |
| 2025-01-23 | 2025-01-21 | TARA | Protara Therapeutics, Inc. | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $4.76 | -6,554 | 95.6K | -6% | -$31.2K | |
| 2025-01-07 | 2025-01-03 | TARA | Protara Therapeutics, Inc. | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $6.14 | -2,157 | 102.1K | -2% | -$13.2K | |
| D | 2024-01-23 | 2024-01-19 | TARA | Protara Therapeutics, Inc. | Zummo Jacqueline | Chf Scientific Ops Off | A - Grant | $0.00 | +23.0K | 107.3K | +27% | $0 |
| D | 2024-01-23 | 2024-01-19 | TARA | Protara Therapeutics, Inc. | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $1.91 | -3,049 | 104.3K | -3% | -$5,824 |
| 2024-01-12 | 2024-01-10 | TARA | Protara Therapeutics, Inc. | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $2.39 | -5,229 | 84.3K | -6% | -$12.5K | |
| 2024-01-05 | 2024-01-03 | TARA | Protara Therapeutics, Inc. | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $2.17 | -1,899 | 89.6K | -2% | -$4,121 | |
| D | 2023-01-20 | 2023-01-19 | TARA | Protara Therapeutics, Inc. | Zummo Jacqueline | Chf Scientific Ops Off | A - Grant | $0.00 | +19.9K | 91.5K | +28% | $0 |
| 2023-01-11 | 2023-01-10 | TARA | Protara Therapeutics, Inc. | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $3.00 | -5,225 | 71.6K | -7% | -$15.7K | |
| 2023-01-04 | 2023-01-03 | TARA | Protara Therapeutics, Inc. | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $2.80 | -2,159 | 76.8K | -3% | -$6,045 | |
| 2022-01-12 | 2022-01-10 | TARA | Protara Therapeutics, Inc. | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $6.27 | -4,603 | 79.0K | -6% | -$28.9K | |
| D | 2022-01-05 | 2022-01-03 | TARA | Protara Therapeutics, Inc. | Zummo Jacqueline | Chf Scientific Ops Off | A - Grant | $0.00 | +14.1K | 83.6K | +20% | $0 |
Purchase Sale Sale after option exercise All abbreviations